Form 10-Q, quarterly report
Immix Biopharma, Inc., 10-Q filed 2026-08-07
Published 7 Aug 2026 · retrieved 8 Aug 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
10-Q filed with the Securities and Exchange Commission by Immix Biopharma, Inc. (CIK 0001873835) on 2026-08-07.
¶2
Accession number 0001493152-26-036643. EDGAR reports the filing package as 6 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1873835/000149315226036643/0001493152-26-036643-index.htm.